Bonescreen is among the winners of the EIT Health Wild Card programme!

EIT Health announced the winners of the 2022 Wild Card programme.

EIT Health announced the two winning teams of its 2022 Wild Card innovation programme – including a winning team from Germany. Since 2017, EIT Health’s Wild Card programme has invited talented innovators, teams and individuals from across Europe and supported them in bringing their new, innovative ideas in the healthcare sector to life through expert mentoring, financial support, and coaching.

Each year, two projects are launched that break new ground, push boundaries and solve some of the biggest challenges in European healthcare. This year, a new class of innovators seized the opportunity to bring their solutions to life and reap the rewards of EIT Health support. The challenges of 2022 entailed the early detection of cancer and mental health, to which innovators from all over Europe were selected to develop their knowledge, skills, and solutions to revolutionise these areas of healthcare. The mental health challenge was looking for applicants contributing to strengthening access to care, accurate diagnosis, and more, while the early cancer detection challenge prompted teams to develop solutions to improve assessment and early detection tools.

“This year’s EIT Health Wild Card Programme attracted some of the greatest minds in innovation, calling upon them to develop unconventional solutions to the challenges of mental health treatment and cancer detection. We are confident that the selected teams will make use of the wealth of expertise and resources on offer to develop their solutions and improve the early detection of cancer. We wish them every luck in this endeavour and enthusiastically support them on their journeys.”- said Kurt Höller, Director of Business Creation at EIT Health.

The German winner, Bonescreen is a MedTech software company based in Munich. As a spin-off of the Technical University of Munich, the team is committed to contributing to a value-based healthcare system. Bonescreen provides non-invasive biomarker extraction and analysis to assist radiologists and clinicians in evaluating diseases related to bone health. The German team´s solution would produce automatically generated reports to help healthcare professionals identify the early signs of cancer at no extra cost to patients or healthcare providers.

Winning the 2022 Wild Card programme, Bonescreen will receive up to €1.5M in investment, mentoring and coaching, and access to our expansive network of investors and innovators across Europe.

Warmest congratulations to Bonescreen for this well-deserved achievement, and of course all the participants!